Showing 1-5 of 5 "aortic stenosis"

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for aortic valve surgery and/or very high risk f ... Read more >

Status: Enrolling

Investigator: Michael Reardon

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a predicted high risk for aortic valve surgery and/or very high risk f ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidi ... Read more >

Status: Open Not Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

To evaluate the safety and efficacy of the CoreValve Evolut R System in patients with severe symptomatic aortic stenosis who are considered at high through extreme risk for surgical aortic valve replacement ... Read more >

Status: Enrolling

Investigator: Neal Kleiman

Study Coordinator: LaShawna Green

Phone: 713.441.6548

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgic ... Read more >